Lycoris Herbert, family Amaryllidaceae, is a small genus of about 20 species that are native to the warm temperate woodlands of eastern Asia, as in China, Korea, Japan, Taiwan, and the Himalayas. For many years, species of Lycoris have been subjected to extensive phytochemical and pharmacological investigations, resulting in either the isolation or identification of more than 110 Amaryllidaceae alkaloids belonging to different structural types. Amaryllidaceae alkaloids are frequently studied for their interesting biological properties, including antiviral, antibacterial, antitumor, antifungal, antimalarial, analgesic, cytotoxic, and cholinesterase inhibition activities. The present review aims to summarize comprehensively the research that has been reported on the phytochemistry and pharmacology of the genus Lycoris.

ADINACO Research Group Department of Pharmaceutical Botany Faculty of Pharmacy Charles University Heyrovského 1203 500 05 Hradec Králové Czech Republic

Zobrazit více v PubMed

Nair J.J., van Staden J. Pharmacological and toxicological insights to the South African Amaryllidaceae. Food Chem. Toxicol. 2013;62:262–275. doi: 10.1016/j.fct.2013.08.042. PubMed DOI

Jin Z. Amaryllidaceae and Sceletium alkaloids. Nat. Prod. Rep. 2016;33:1318–1343. doi: 10.1039/C6NP00068A. PubMed DOI

Fennell C., van Staden J. Crinum species in traditional and modern medicine. J. Ethnopharmacol. 2001;78:15–26. doi: 10.1016/S0378-8741(01)00305-1. PubMed DOI

Havelek R., Muthna D., Tomsik P., Kralovec K., Seifrtova M., Cahlikova L., Hostalkova A., Safratova M., Perwein M., Cermakova E., et al. Anticancer potential of Amaryllidaceae alkaloids evaluated by screening with a panel of human cells, real-time cellular analysis and Ehrlich tumor-bearing mice. Chem. Biol. Interact. 2017;275:121–132. doi: 10.1016/j.cbi.2017.07.018. PubMed DOI

Vaněčková N., Hošt‘álková A., Šafratová M., Kuneš J., Hulcová D., Hrabinová M., Doskočil I., Štěpánková Š., Opletal L., Nováková L., et al. Isolation of Amaryllidaceae alkaloids from Nerine bowdenii W. Watson and their biological activities. RSC Adv. 2016;6:80114–80120. doi: 10.1039/C6RA20205E. DOI

Kornienko A., Evidente A. Chemistry, biology, and medicinal potential of narciclasine and its congeners. Chem. Rev. 2008;108:1982–2014. doi: 10.1021/cr078198u. PubMed DOI PMC

Marco L., do Carmo Carreiras M. Galanthamine, a natural product for the treatment of Alzheimer’s disease. Recent Pat. CNS Drug Discov. 2006;1:105–111. doi: 10.2174/157488906775245246. PubMed DOI

Tae K., Ko S. New taxa of the genus Lycoris. Korean J. Plant Taxon. 1993;23:233–241. doi: 10.11110/kjpt.1993.23.4.233. DOI

Tae K., Ko S. A taxonomic study on the genus Lycoris (Amaryllidaceae) Korean J. Plant Taxon. 1996;26:19–35. doi: 10.11110/kjpt.1996.26.1.019. DOI

Ping-Sheng H.S.U., Kurita S., Zhi-Zhou Y.U., Jin-Zhen L.I.N. Synopsis of the genus Lycoris (Amaryllidaceae) Sida. 1994;16:301–331.

The Plant List. [(accessed on 10 September 2020)]; Available online: http://www.theplantlist.org/tpl1.1/search?q=Lycoris.

Chen G.-L., Tian Y.-Q., Wu J.-L., Li N., Guo M.-Q. Antiproliferative activities of Amaryllidaceae alkaloids from Lycoris radiata targeting DNA topoisomerase I. Sci. Rep. 2016;6:38284. doi: 10.1038/srep38284. PubMed DOI PMC

Feng T., Wang Y.-Y., Su J., Li Y., Cai X.-H., Luo X.-D. Amaryllidaceae alkaloids from Lycoris Radiata. Helv. Chim. Acta. 2011;94:178–183. doi: 10.1002/hlca.201000176. DOI

Huang S.-D., Zhang Y., He H.-P., Li S.-F., Tang G.-H., Chen D.-Z., Cao M.-M., Di Y.-T., Hao X.-J. A new Amaryllidaceae alkaloid from the bulbs of Lycoris radiata. Chin. J. Nat. Med. 2013;11:406–410. doi: 10.3724/SP.J.1009.2013.00406. PubMed DOI PMC

Wang L., Zhang X.Q., Yin Z.Q., Wang Y., Ye W.C. Two new Amaryllidaceae alkaloids from the bulbs of Lycoris Radiata. Chem. Pharm. Bull. 2009;57:610–611. doi: 10.1248/cpb.57.610. PubMed DOI

Shen C.-Y., Xu X.-L., Yang L.-J., Jiang J.-G. Identification of narciclasine from Lycoris radiata (L’Her.) Herb. and its inhibitory effect on LPS-induced inflammatory responses in macrophages. Food Chem. Toxicol. 2019;125:605–613. doi: 10.1016/j.fct.2019.02.003. PubMed DOI

Cao Z., Yang P., Zhou Q. Multiple biological functions and pharmacological effects of lycorine. Sci. China Chem. 2013;56:1382–1391. doi: 10.1007/s11426-013-4967-9. PubMed DOI PMC

Jin Z. Amaryllidaceae and Sceletium alkaloids. Nat. Prod. Rep. 2011;28:1126–1142. doi: 10.1039/c0np00073f. PubMed DOI

Duke J.A., Ayensu E.S. Medicinal Plants of China. 2nd ed. Reference Publications; Algonac, MI, USA: 1985. p. 398.

Chase M., Reveal J., Fay M. A subfamilial classification for the expanded asparagalean families Amaryllidaceae, Asparagaceae and Xanthorrhoeaceae. Bot. J. Linn. Soc. 2009;161:132–136. doi: 10.1111/j.1095-8339.2009.00999.x. DOI

Kilgore M.B., Kutchan T.M. The Amaryllidaceae alkaloids: Biosynthesis and methods for enzyme discovery. Phytochem. Rev. 2016;15:317–337. doi: 10.1007/s11101-015-9451-z. PubMed DOI PMC

Armengol J.B.I., Berkov S., Claveria L.T., Pigni N.B., de Andrade J.P., Martínez V., Mahrer C.C., Meya F.V. Chemical and biological aspects of Amaryllidaceae alkaloids. In: Muñoz-Torrero D., editor. Recent Advances in Pharmaceutical Sciences. Transworld Research Network; Kerala, India: 2011. pp. 65–100.

Desgagne-Penix I. Biosynthesis of the Amaryllidaceae alkaloids. Plant Sci. Today. 2014;1:114–120.

Berkov S., Martínez-Francés V., Bastida J., Codina C., Ríos S. Evolution of alkaloid biosynthesis in the genus Narcissus. Phytochemistry. 2014;99:95–106. doi: 10.1016/j.phytochem.2013.11.002. PubMed DOI

Cahlíková L., Vaněčková N., Safratova M., Breiterová K., Blunden G., Hulcova D., Opletal L. The genus Nerine Herb. (Amaryllidaceae): Ethnobotany, phytochemistry, and biological activity. Molecules. 2019;24:4238. doi: 10.3390/molecules24234238. PubMed DOI PMC

Desgagné-Penix I. Biosynthesis of alkaloids in Amaryllidaceae plants: A review. Phytochem. Rev. 2020;5:239–270. doi: 10.1007/s11101-020-09678-5. DOI

Ang S., Liu X.M., Huang X.J., Zhang D.M., Zhang W., Wang L., Ye W.C. Four new Amaryllidaceae alkaloids from Lycoris radiata and their cytotoxicity. Planta Med. 2015;81:1712–1718. doi: 10.1055/s-0035-1557743. PubMed DOI

Yan H., Xie N., Zhong C., Su A., Hui X., Zhang X., Jin Z., Li Z., Feng J., He J. Aphicidal activities of Amaryllidaceae alkaloids from bulbs of Lycoris radiata against Aphis citricola. Ind. Crop. Prod. 2018;123:372–378. doi: 10.1016/j.indcrop.2018.06.082. DOI

Berkov S., Osorio E., Viladomat F., Bastida J. Chapter Two-Chemodiversity, chemotaxonomy and chemoecology of Amaryllidaceae alkaloids. In: Knölker H.-J., editor. The Alkaloids: Chemistry and Biology. Volume 83. Academic Press; Cambridge, MA, USA: 2020. pp. 113–185. PubMed

Zhu Y.-Y., Li X., Yu H.-Y., Xiong Y.-F., Zhang P., Pi H.-F., Ruan H.-L. Alkaloids from the bulbs of Lycoris longituba and their neuroprotective and acetylcholinesterase inhibitory activities. Arch. Pharm. Res. 2014;38:604–613. doi: 10.1007/s12272-014-0397-2. PubMed DOI

Jin A., Li X., Zhu Y.Y., Yu H.Y., Pi H.F., Zhang P., Ruan H.L. Four new compounds from the bulbs of Lycoris aurea with neuroprotective effects against CoCl2 and H2O2-induced SH-SY5Y cell injuries. Arch. Pharm. Res. 2014;37:315–323. doi: 10.1007/s12272-013-0188-1. PubMed DOI

Tian Y., Zhang C., Guo M. Comparative analysis of Amaryllidaceae alkaloids from three Lycoris species. Molecules. 2015;20:21854–21869. doi: 10.3390/molecules201219806. PubMed DOI PMC

Zhang X., Huang H., Liang X., Huang H., Dai W., Shen Y., Yan S., Zhang W. Analysis of Amaryllidaceae alkaloids from Crinum by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry. Rapid. Commun. Mass Spectrom. 2009;23:2903–2916. doi: 10.1002/rcm.4205. PubMed DOI

Takayama H., Kinoshita E., Kitajima M., Kogure N. Two new alkaloids from bulbs of Lycoris squamigera. Heterocycles. 2009;77:1389–1396. doi: 10.3987/COM-08-S(F)92. DOI

Li H., Ma G., Xu Y., Hong S. Alkaloids of Lycoris Guangxiensis. Planta Med. 1987;53:259–261. doi: 10.1055/s-2006-962697. PubMed DOI

Kihara M., Xu L., Konishi K., Kida K., Nagao Y., Kobayashi S., Shingu T. Isolation and structure elucidation of a novel alkaloid, incartine, a supposed biosynthetic intermediate, from flowers of Lycoris incarnata. Chem. Pharm. Bull. 1994;42:289–292. doi: 10.1248/cpb.42.289. DOI

Li X., Yu H.Y., Wang Z.Y., Pi H.F., Zhang P., Ruan H.L. Neuroprotective compounds from the bulbs of Lycoris radiata. Fitoterapia. 2013;88:82–90. doi: 10.1016/j.fitote.2013.05.006. PubMed DOI

Kihara M., Konishi K., Xu L., Kobayashi S. Alkaloidal constituents of the flowers of Lycoris radiata HERB: Amaryllidaceae. Chem. Pharm. Bull. 1991;39:1849–1853. doi: 10.1248/cpb.39.1849. DOI

Jitsuno M., Yokosuka A., Hashimoto K., Amano O., Sakagami H., Mimaki Y. Chemical constituents of Lycoris albiflora and their cytotoxic activities. Nat. Prod. Commun. 2011;6:1934578X1100600208. doi: 10.1177/1934578X1100600208. PubMed DOI

Boit H.G., Döpke W., Stender W. Alkaloide aus Hippeastrum rutilum, Lycoris albiflora, Zephyranthes andersoniana und Sternbergia fischeriana. Naturwissenschaften. 1958;45:390. doi: 10.1007/BF00678524. DOI

Guo Y., Pigni N., Zheng Y., de Andrade J., Torras-Claveria L., Borges W., Francesc V., Codina C., Bastida J. Analysis of bioactive Amaryllidaceae alkaloid profiles in Lycoris species by GC-MS. Nat. Prod. Commun. 2014;9:1081–1086. doi: 10.1177/1934578X1400900806. PubMed DOI

Boit H.-G., Ehmke H. XVI. Mitteil. über Amaryllidaceen-Alkaloide. Alkaloide von Nerine corusca, N. flexuosa, Pancratium illyricum, Lycoris aurea und L. Incarnata. Chem. Ber. 1957;90:369–373. doi: 10.1002/cber.19570900311. DOI

Mu H.M., Wang R., Li X.D., Jiang Y.M., Peng F., Xia B. Alkaloid accumulation in different parts and ages of Lycoris Chinensis. Z. Nat. C. 2010;65:458–462. doi: 10.1515/znc-2010-7-807. PubMed DOI

Wu W.-M., Zhu Y.-Y., Li H.-R., Yu H.-Y., Zhang P., Pi H.-F., Ruan H.-L. Two new alkaloids from the bulbs of Lycoris sprengeri. J. Asian Nat. Prod. Res. 2014;16:192–199. doi: 10.1080/10286020.2013.864639. PubMed DOI

Toriizuka Y., Kinoshita E., Kogure N., Kitajima M., Ishiyama A., Otoguro K., Yamada H., Ōmura S., Takayama H. New lycorine-type alkaloid from Lycoris traubii and evaluation of antitrypanosomal and antimalarial activities of lycorine derivatives. Bioorganic Med. Chem. 2008;16:10182–10189. doi: 10.1016/j.bmc.2008.10.061. PubMed DOI

Wang L., Yin Z.-Q., Cai Y., Zhang X.-Q., Yao X.-S., Ye W.-C. Amaryllidaceae alkaloids from the bulbs of Lycoris Radiata. BioChem. Syst. Ecol. 2010;38:444–446. doi: 10.1016/j.bse.2010.02.005. DOI

Hao B., Shen S.F., Zhao Q.J. Cytotoxic and antimalarial Amaryllidaceae alkaloids from the bulbs of Lycoris radiata. Molecules. 2013;18:2458–2468. doi: 10.3390/molecules18032458. PubMed DOI PMC

Liu Z.-M., Huang X.-Y., Cui M.-R., Zhang X.-D., Chen Z., Yang B.-S., Zhao X.-K. Amaryllidaceae alkaloids from the bulbs of Lycoris radiata with cytotoxic and anti-inflammatory activities. Fitoterapia. 2015;101:188–193. doi: 10.1016/j.fitote.2015.01.003. PubMed DOI

Liao N., Ao M., Zhang P., Yu L. Extracts of Lycoris aurea induce apoptosis in murine sarcoma S180 cells. Molecules. 2012;17:3723–3735. doi: 10.3390/molecules17043723. PubMed DOI PMC

Song J.-H., Zhang L., Song Y. Alkaloids from Lycoris aurea and their cytotoxicities against the head and neck squamous cell carcinoma. Fitoterapia. 2014;95:121–126. doi: 10.1016/j.fitote.2014.03.006. PubMed DOI

Deng B., Ye L., Yin H., Liu Y., Hu S., Li B. Determination of pseudolycorine in the bulb of Lycoris radiata by capillary electrophoresis combined with online electrochemiluminescence using ultrasonic-assisted extraction. J. Chromatogr. B. 2011;879:927–932. doi: 10.1016/j.jchromb.2011.03.002. PubMed DOI

Cao P., Pan D.S., Han S., Yu C.Y., Zhao Q.J., Song Y., Liang Y. Alkaloids from Lycoris caldwellii and their particular cytotoxicities against the astrocytoma and glioma cell lines. Arch. Pharm. Res. 2013;36:927–932. doi: 10.1007/s12272-013-0089-3. PubMed DOI

Yun Y.S., Tajima M., Takahashi S., Takahashi Y., Umemura M., Nakano H., Park H.S., Inoue H. Two alkaloids from bulbs of Lycoris sanguinea MAXIM. suppress PEPCK expression by inhibiting the phosphorylation of CREB. Phytother. Res. 2016;30:1689–1695. doi: 10.1002/ptr.5676. PubMed DOI

Pi H.F., Zhang P., Ruan H.L., Zhang Y.H., Sun H.D., Wu J.Z. A new alkaloid from Lycoris aurea. Chin. Chem. Lett. 2009;20:1319–1320. doi: 10.1016/j.cclet.2009.06.003. DOI

Nair J.J., van Staden J. Cytotoxicity studies of lycorine alkaloids of the Amaryllidaceae. Nat. Prod. Commun. 2014;9:1934578X1400900834. doi: 10.1177/1934578X1400900834. PubMed DOI

Habartová K., Cahlíková L., Řezáčová M., Havelek R. The biological activity of alkaloids from the Amaryllidaceae: From cholinesterases inhibition to anticancer activity. Nat. Prod. Commun. 2016;11:1934578X1601101038. doi: 10.1177/1934578X1601101038. PubMed DOI

Nair J.J., Rárová L., Strnad M., Bastida J., van Staden J. Mechanistic insights to the cytotoxicity of Amaryllidaceae alkaloids. Nat. Prod. Commun. 2015;10:1934578X1501000138. doi: 10.1177/1934578X1501000138. PubMed DOI

Nair J.J., Bastida J., Viladomat F., van Staden J. Cytotoxic agents of the crinane series of Amaryllidaceae alkaloids. Nat. Prod. Commun. 2013;8:1934578X1300800501. doi: 10.1177/1934578X1300800501. PubMed DOI

McNulty J., Nair J.J., Bastida J., Pandey S., Griffin C. Structure-activity studies on the lycorine pharmacophore: A potent inducer of apoptosis in human leukemia cells. Phytochemistry. 2009;70:913–919. doi: 10.1016/j.phytochem.2009.04.012. PubMed DOI PMC

Evdokimov N.M., Lamoral-Theys D., Mathieu V., Andolfi A., Frolova L.V., Pelly S.C., van Otterlo W.A., Magedov I.V., Kiss R., Evidente A., et al. In search of a cytostatic agent derived from the alkaloid lycorine: Synthesis and growth inhibitory properties of lycorine derivatives. Bioorganic Med. Chem. 2011;19:7252–7261. doi: 10.1016/j.bmc.2011.09.051. PubMed DOI PMC

Griffin C., Sharda N., Sood D., Nair J., McNulty J., Pandey S. Selective cytotoxicity of pancratistatin-related natural Amaryllidaceae alkaloids: Evaluation of the activity of two new compounds. Cancer Cell Int. 2007;7:10. doi: 10.1186/1475-2867-7-10. PubMed DOI PMC

Cahlíková L., Kawano I., Rezáčová M., Blunden G., Hulcova D., Havelek R. The Amaryllidaceae alkaloids haemanthamine, haemanthidine and their semisynthetic derivatives as potential drugs. Phytochem. Rev. 2020;26:1519–1524. doi: 10.1007/s11101-020-09675-8. DOI

Lefranc F., Sauvage S., Goietsenoven G., Mégalizzi V., Lamoral-Theys D., Debeir O., Spiegl-Kreinecker S., Berger W., Mathieu V., Decaestecker C., et al. Narciclasine, a plant growth modulator, activates Rho and stress fibers in glioblastoma cells. Mol. Cancer. 2009;8:1739–1750. doi: 10.1158/1535-7163.MCT-08-0932. PubMed DOI

Pettit G.R., Pettit G.R., Backhaus R.A., Boyd M.R., Meerow A.W. Antineoplastic agents, 256. Cell growth inhibitory isocarbostyrils from Hymenocallis. J. Nat. Prod. 1993;56:1682–1687. doi: 10.1021/np50100a004. PubMed DOI

Van Goietsenoven G., Hutton J., Becker J.-P., Lallemand B., Robert F., Lefranc F., Pirker C., Vandenbussche G., Van Antwerpen P., Evidente A., et al. Targeting of eEF1A with Amaryllidaceae isocarbostyrils as a strategy to combat melanomas. FASEB J. 2010;24:4575–4584. doi: 10.1096/fj.10-162263. PubMed DOI PMC

Gopalakrishnan R., Matta H., Choi S., Chaudhary P. Narciclasine, an isocarbostyril alkaloid, has preferential activity against primary effusion lymphoma. Sci. Rep. 2020;10:5712. doi: 10.1038/s41598-020-62690-9. PubMed DOI PMC

Dumont P., Ingrassia L., Rouzeau S., Ribaucour F., Thomas S., Roland I., Darro F., Lefranc F., Kiss R. The Amaryllidaceae isocarbostyril narciclasine induces apoptosis by activation of the death receptor and/or mitochondrial pathways in cancer cells but not in normal fibroblasts 1. Neoplasia. 2007;9:766–776. doi: 10.1593/neo.07535. PubMed DOI PMC

Van Goietsenoven G., Mathieu V., Lefranc F., Kornienko A., Evidente A., Kiss R. Narciclasine as well as other Amaryllidaceae isocarbostyrils are promising GTP-ase targeting agents against brain cancers. Med. Res. Rev. 2013;33:439–455. doi: 10.1002/med.21253. PubMed DOI

Stark A., Schwenk R., Wack G., Zuchtriegel G., Hatemler M., Bräutigam J., Schmidtko A., Reichel C., Bischoff I., Fürst R. Narciclasine exerts anti-inflammatory actions by blocking leukocyte–endothelial cell interactions and down-regulation of the endothelial TNF receptor 1. FASEB J. 2019;33:8771–8781. doi: 10.1096/fj.201802440R. PubMed DOI

Nordberg A., Ballard C., Bullock R., Darreh-Shori T., Somogyi M. A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer’s disease. Prim. Care Companion CNS Disord. 2013;15 doi: 10.4088/PCC.12r01412. PubMed DOI PMC

Yu W., Hao W., Hong-zhuan C. AChE Inhibition-based multi-target-directed ligands, a novel pharmacological approach for the symptomatic and disease-modifying therapy of Alzheimer’s Disease. Curr. Neuropharmacol. 2016;14:364–375. PubMed PMC

De Vita D., Pandolfi F., Ornano L., Feroci M., Chiarotto I., Sileno I., Pepi F., Costi R., Di Santo R., Scipione L. New N,N-dimethylcarbamate inhibitors of acetylcholinesterase: Design, synthesis and biological evaluation. J. Enzym. Inhib. Med. Chem. 2016;31:106–113. doi: 10.1080/14756366.2016.1220377. PubMed DOI

Al Mamun A., Maříková J., Hulcová D., Janoušek J., Šafratová M., Nováková L., Kučera T., Hrabinová M., Kuneš J., Korábečný J., et al. Amaryllidaceae alkaloids of belladine type from Narcissus pseudonarcissus cv. Carlton as new selective inhibitors of butyrylcholinesterase. Biomolecules. 2020;10:800. doi: 10.3390/biom10050800. PubMed DOI PMC

Hulcová D., Maříková J., Korábečný J., Hošťálková A., Jun D., Kuneš J., Chlebek J., Opletal L., De Simone A., Nováková L., et al. Amaryllidaceae alkaloids from Narcissus pseudonarcissus L. cv. Dutch Master as potential drugs in treatment of Alzheimer’s disease. Phytochemistry. 2019;165:112055. doi: 10.1016/j.phytochem.2019.112055. PubMed DOI

Moreno R., Tallini L.R., Salazar C., Osorio E.H., Montero E., Bastida J., Oleas N.H., Acosta León K. Chemical profiling and cholinesterase inhibitory activity of five Phaedranassa Herb. (Amaryllidaceae) species from Ecuador. Molecules. 2020;25:2092. doi: 10.3390/molecules25092092. PubMed DOI PMC

T Tallini L.R., Bastida J., Cortes N., Osorio E.H., Theoduloz C., Schmeda-Hirschmann G. Cholinesterase inhibition activity, alkaloid profiling and molecular docking of Chilean Rhodophiala (Amaryllidaceae) Molecules. 2018;23:1532. doi: 10.3390/molecules23071532. PubMed DOI PMC

Tiwari M.K., Chaudhary S. Artemisinin-derived antimalarial endoperoxides from bench-side to bed-side: Chronological advancements and future challenges. Med. Res. Rev. 2020;40:1220–1275. doi: 10.1002/med.21657. PubMed DOI

Dedryver C.-A., Le Ralec A., Fabre F. The conflicting relationships between aphids and men: A review of aphid damage and control strategies. Comptes Rendus Biol. 2010;333:539–553. doi: 10.1016/j.crvi.2010.03.009. PubMed DOI

Liu B., Gao X., Zheng B. Effects of sublethal doses of anticholinesterase agents on toxicity of insecticides and their induction to acetylcholinesterase (AChE) activity in Helicoverpa armigera. Acta Entomol. Sin. 2003;46:691–696.

Recent Progress on Biological Activity of Amaryllidaceae and Further Isoquinoline Alkaloids in Connection with Alzheimer's Disease